Pivotal pharmacokinetic trial to compare topical diclofenac 2% (Pennsaid 2%) and topical diclofenac 1.5% (Pennsaid)
Phase of Trial: Phase I
Latest Information Update: 01 May 2014
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Pharmacokinetics; Registrational
- 01 May 2014 Results will be presented at American Pain Society Annual Scientific Meeting.
- 15 Aug 2013 Trial results have been submitted to the US FDA by Mallinckrodt, the US licensing partner, according to a Nuvo Research media release.
- 23 Jul 2013 Status changed from recruiting to completed, according to a Nuvo Research media release.